As of July 2022 BiondVax has a market cap of $0.02 Billion. This makes BiondVax the world's 6194th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $0.02 B | -49.59% |
2021 | $0.04 B | 34.05% |
2020 | $0.03 B | -65.34% |
2019 | $0.09 B | 199.75% |
2018 | $0.03 B | -11.01% |
2017 | $0.03 B | 209.61% |
2016 | $0.01 B | -15.4% |
2015 | $0.01 B |
On Jul 2nd, 2022 the market cap of BiondVax was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | $0.17 B | 693.68% | ๐บ๐ธ USA |